Without admitting wrongdoing, the atrial fibrillation company finalizes an agreement to pay $3.8 million to settle Justice Dept. charges that it ran an illegal kickbacks and off-label marketing program aimed at boosting Medicare payments for its procedure.
AtriCure Inc. (NSDQ:ATRC) finalized a deal to pay $3.76 million over five years to settle a federal beef accusing it of running an illegal kickbacks and off-label marketing program for its atrial fibrillation devices, according to the U.S.Justice Dept.
In November, the West Chester, Ohio-based company said it tentatively settled a federal "qui tam" whistleblower lawsuit and a separate DOJ investigation. The terms of the final deal, like the tentative agreement reached last fall, "specifically state that AtriCure and its employees admit no wrongdoing or illegal activity,”according to an Atricure press release.
In November, the company said it set aside $3.8 million to cover the tentative settlement.
The lawsuit accused AtriCure of offering kickbacks to induce surgeons and hospitals to use its inpatient cardiac ablation procedure rather than less expensive, outpatient alternatives. The company was accused of promoting the spread between Medicare reimbursement rates for its procedure and the cost to hospitals and doling out kickbacks including free equipment, discounts, free advertising, marketing, and referral services and training for surgeons on its procedure.
The finalized settlement will see the company pay annual penalties (including interest) of $500,000, $500,000, $650,000, $1 million and $1.5 million.
AtriCure shares were down about 1 percent to $5.80 at 3:10 p.m.
The FDA labels as Class I CareFusion's recall of its Avea ventilators over a possibly fatal...
Small medtech companies are finding value in outsourcing their research & development functions,...
VertiFlex says it won pre-market approval from the FDA for its Superion interspinous spacer.
China is investigating a former top healthcare official on suspicion of bribery.
Medtronic is reportedly looking to grow its presence in China with lower-cost devices, as well as...